Diopsys Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
M&A
Diopsys General Information
Description
Producer of visual electrophysiology and non-invasive diagnostic vision testing systems designed to provide vision disorder detection and vision testing services. The company's vision testing systems are designed to provide ophthalmologists and optometrists with objectives and functional information about the vision system, enabling users in the early detection of vision disorders thereby enhancing patient management through ERG and VEP vision testing.
Contact Information
Website
www.diopsys.comCorporate Office
- 16 Chapin Road, P.O. Box 672
- Suite 911-912
- Pine Brook, NJ 07058
- United States
Corporate Office
- 16 Chapin Road, P.O. Box 672
- Suite 911-912
- Pine Brook, NJ 07058
- United States
Diopsys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 05-Mar-2022 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 23-Mar-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 28-Feb-2007 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 17-Nov-2005 | $2.09M | $2.83M | Completed | Generating Revenue | |
| 1. Early Stage VC | 24-May-2002 | $747K | $747K | Completed | Startup |
Diopsys Comparisons
Industry
Financing
Details
Diopsys Competitors (4)
One of Diopsys’s 4 competitors is Sensimed, a Formerly VC-backed company based in Etagnières, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sensimed | Formerly VC-backed | Etagnières, Switzerland | ||||
| Implandata Ophthalmic Products | Venture Capital-Backed | Hanover, Germany | ||||
| OmniGuide | Venture Capital-Backed | Billerica, MA | ||||
| Visionix (Diagnostic Equipment) | Formerly PE-Backed | Pont-de-l'Arche, France |
Diopsys Patents
Diopsys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140142409-A1 | Electrode sensor assembly for electroretinography and pattern electroretinography | Active | 16-Nov-2012 | ||
| US-9026189-B2 | Electrode sensor assembly for electroretinography and pattern electroretinography | Active | 16-Nov-2012 | ||
| CA-2878944-A1 | Signal data extraction method and apparatus | Active | 20-Jul-2012 | ||
| CA-2878944-C | Signal data extraction method and apparatus | Active | 20-Jul-2012 | ||
| EP-2874534-A1 | Signal data extraction method and apparatus | Active | 20-Jul-2012 | A61B5/7282 |
Diopsys Signals
Diopsys Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority |
Diopsys FAQs
-
When was Diopsys founded?
Diopsys was founded in 1998.
-
Where is Diopsys headquartered?
Diopsys is headquartered in Pine Brook, NJ.
-
What is the size of Diopsys?
Diopsys has 52 total employees.
-
What industry is Diopsys in?
Diopsys’s primary industry is Diagnostic Equipment.
-
Is Diopsys a private or public company?
Diopsys is a Private company.
-
What is Diopsys’s current revenue?
The current revenue for Diopsys is .
-
How much funding has Diopsys raised over time?
Diopsys has raised $10.6M.
-
Who are Diopsys’s investors?
has invested in Diopsys.
-
Who are Diopsys’s competitors?
Sensimed, Implandata Ophthalmic Products, OmniGuide, and Visionix (Diagnostic Equipment) are competitors of Diopsys.
-
When was Diopsys acquired?
Diopsys was acquired on 05-Mar-2022.
-
Who acquired Diopsys?
Diopsys was acquired by LumiThera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process